Status:
COMPLETED
Radiomics for Tumor Grading of Soft Tissue Sarcomas.
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
University of Washington
Conditions:
Sarcoma, Soft Tissue
Eligibility:
All Genders
Brief Summary
Radiomics is defined as a quantitative high-throughput analysis of imaging data combined with model development aiming to predict biological correlates or clinical endpoints. The investigators of this...
Detailed Description
Soft tissue sarcomas (STS) constitute an overall rare malignant entity comprising 1% of all cancers with a yearly incidence rate of 3.8 per 100.000 inhabitants. Therapy decisions are made using clinic...
Eligibility Criteria
Inclusion
- Histologically proven soft tissue sarcoma
- Available pre-therapeutic MRI with a contrast-enhanced T1 weight fat saturated sequence +/- fat saturated T2 sequences (e.g. STIR)
Exclusion
- Indeterminate tumor grading
- Osteosarcoma
- Ewing Sarcoma
- Endoprothesis-dependent MRI artifacts
- Previous radiotherapy or chemotherapy
- Lack of a contrast-enhanced T1 weight fat saturated MRI sequence
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
285 Patients enrolled
Trial Details
Trial ID
NCT03798795
Start Date
October 1 2017
End Date
March 1 2019
Last Update
April 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für RadioOnkologie Strahlentherapie
Munich, Bavaria, Germany, 81675